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Abstract  Background: Celiac is a chronic hereditary intestinal disorder caused by autoimmune 
stimulation and injury of intestinal mucosa and different studies have reported an increase of inflammatory cytokines 
production in these patients. This study aimed to investigate the serum level of inflammatory cytokines and their 
correlations with the severity of histological variations among celiac patients. Material and methods: By a cross 
sectional study all celiac patients attending to gastrointestinal clinics in Ilam city during Oct. 2011- MAR. 2013 were 
investigated. Demographic data was collected using a validate questionnaire and patient's interview and each patient 
was taken a blood sample for laboratory investigation of tTG-IgA antibody via Elisa test and the serum level of hs-
CRP, IL-6 and TNF-a was measured. All patients underwent endoscopic evaluation and biopsy samples were 
evaluated according to Marsh classification and correlation between severity of histological variations and serum 
levels of inflammatory cytokines was measured. Results: Totally 274 patients including 90 male and 184 female 
with a mean age of 28.8±14.4 years were evaluated. The mean serum levels of hs-CRP, IL-6 and TNF-a were 
7.8±3.1 mg/l, 2.6±0.9 pg/ml and 6.9±4.6 pg/ml respectively (p=0.599, p=0.629 and p= 0.651). Hs-CRP showed a 
significant relationship with the severity of mucosal damage upon class I of Marsh classification (p=0.01); however, 
IL-6 showed a significant level among patients with Marsh I, II and IIIC (p=0.000, p=0.02 and p=0.000) but not in 
those with Marsh class IIIA and IIIB. Conclusion: There was a positive relationship between mean serum levels of 
IL-6 and TNF-a with increasing the Marsh classification from class I to class IIIC and the highest rate of IL-6 and 
TNF-a was shown in Marsh IIIC but the serum level of hs-CRP was not increased with Marsh class increasing. It 
was concluded that as the Marsh classification increased from class I to class IIIC, and/or the severity of pathologic 
variations was increased, the mean serum levels of inflammatory markers were increased too. 
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1. Introduction 
Celiac disease is a chronic hereditary disorder caused 
by damages of intestinal mucosa due to consumption of 
foods with gluten [1]. A classic definition of celiac is a 
disease accompanied with villous atrophy and 
malabsorption signs such as steatorrhea, weight loss and 
other food related symptoms which will be cured during 
several weeks after gluten free regimen [2]. According to 
the Modified Marsh classification the pathologic 
variations of intestinal mucosa is divided into 5 categories 
including Marsh I (secretion of lymphocytes inside the 
lamina propia and >40 intraepithelial lymphocytes/ 100 
epithelial cells), Marsh II (hypertrophy of crypts without 
villous atrophy), Marsh IIIA (partial villous atrophy), 
Marsh IIIB (subtotal villous atrophy) and Marsh IIIC 
(total villous atrophy) [3]. Development of these 
pathologic variations is associated with the sensitivity and 
reaction rates of patients to gluten and improvement of 
these variations is associated with the elimination of 
gluten in their daily regimens [4]. TCD4 cells sensitive to 
gluten, via secretion of INF-c, cause activation of pre-
inflammatory responses such as metalloproteinase 
activation that result in mucosal damages and villous 
atrophy. Also, metalloproteinase causes TNF-a secretion 
from intestinal myofibroblasts [5]. Studies on T cells of 
intestinal lamina propia reported that cytokines profile in 
celiac patients are mostly consisted TNF-a and INF-C [6]. 
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Cytokines are the intracellular proteins that have main 
roles in the regulation of immunology and inflammatory 
reactions of body [6,7]. Also CRP is a systemic 
inflammatory biomarker that is widely used for the 
diagnosis of acute or chronic inflammatory diseases [8] 
and its laboratory measurement is easy, inexpensive and 
accessible [4]. This marker has a predictor role for 
inflammation and malignancy and its serum level is 
increased during different malignancies. Prospective 
studies have shown the higher risk of malignancy among 
patients with higher serum level of CRP [9,10,11]. This 
marker is appeared in peripheral blood after infection, 
trauma, myocardial diseases and inflammatory diseases, 
such as rheumatoid arthritis, Crown's disease, and it is 
produced by liver in response to inflammatory cytokines 
such as IL1, TNF-a and IL6 [11,12]. Studies have shown 
that the production rate of cytokines by immunological 
cells of mucosa is associated with the severity rate of 
mucosal cells damages in celiac patients [13]. This study 
aimed to investigate the serum level of inflammatory 
cytokines and their correlations with the severity of 
histological variations among celiac patients.  
2. Material and Methods 
2.1. Patients Selection 
By a cross-sectional study all patients attended to 
gastrointestinal clinics in Ilam city, west of Iran, during 
Oct. 2011 to April 2013 with a history of celiac symptoms 
were evaluated and those with confirmed diagnosis of 
celiac were entered into the study. Celiac disease was 
defined as a digestive disease caused by an immune 
reaction to eating gluten and this reaction produces 
inflammation that damages the small intestine's mucosa 
and prevents absorption of some nutrients resulting in 
weight loss, bloating and sometimes diarrhea. Using a 
validated questionnaire demographic data of participants 
were collected via patients' interview. Each patient was 
taken a sample of venous blood and samples were sent to 
a reference laboratory for ELISA testing of tTG- IgA 
antibody. Serologic amounts more than 25 U/ml were 
considered as sero-positive. Excluding criteria were serum 
level of tTG-IgA antibody less than 25 U/ml, IgA 
deficiency, patients with liver diseases, autoimmune 
disorders and IBD.  
2.2. Laboratory Investigations 
Serum level of hs-CRP was measured using Pars 
Azmon kits and serum levels of IL6 and TNF-a by Bender 
Kits, all via ELISA method.  
2.3. Endoscopic and Pathologic Evaluations 
All patients underwent upper endoscopic evaluations, 
using Olympus endoscopic equipment and each patient 
was taken 4 biopsy samples of intestinal mucosa in 
different sections of second part of duodenum. Biopsy 
samples were then sent for pathological investigations and 
Marsh classifications by an expert pathologist upon 
Modified Marsh classifications. 
Demographic and laboratory data were then entered 
into SPSS 16 and mean±SD of serum levels of different 
markers were measured. Quantitative and qualitative data 
were tested using T- test and ANOVA respectively and 
correlations between mean serum levels of different 
markers and mucosal damages were tested using Pearson 
correlation coefficient test. A p-value less than 0.05 was 
considered as significant.  
3. Results 
Table 1. Frequency of different classes of intestinal involvements and mean serum levels of different markers according to gender in celiac 
patients 
P value Total Female Male Variable 
0.24 28.82 29.54 27.36 Mean age (year) 
0.03 284 174 90 Gender (n) 
0.49 44 (16.1) 29 (65.9) 15 (34.1) I 
Marsh classification number (%) 
0.36 72 (26.3) 46 (63.9) 26 (36.1) II 
0.07 46 (16.8) 26 (56.5) 20 (43.5) IIIA 
0.56 54 (19.7) 37 (68.5) 17 (31.5) IIIB 
0.02 58 (21.2) 45 (78.9) 12 (21.1) IIIC 
0.6 7.75 7.65 7.95 Hs-CRP 
Mean level of Inflammatory markers 0.63 2.61 2.63 2.57 IL-6 
0.65 6.9 6.81 7.09 TNF-a 
Totally 274 patients including 90 male and 184 female 
with a mean age of 28.8±14.4 years were evaluated. 
Marsh classifications of samples according to patients' 
gender and different serum levels of investigated markers 
are indicated in Table 1. The mean serum levels of hs-
CRP, IL-6 and TNF-a were 7.8±3.1 mg/l, 2.6±0.9 pg/ml 
and 6.9±4.6 pg/ml respectively (p=0.60, p=0.63 and p= 
0.65). Marsh II was the most common with a mean figure 
of 26.3% followed by Marsh III c (21.1%). Female were 
more affected by celiac disease according to pathologic 
reports and in all Marsh classifications the percentages of 
intestinal involving among female were more than male; 
however, only Marsh IIIc showed a significant difference 
between male and female (p<0.02). Mean± SD of hs-CRP 
was high among patients with Marsh I with a significant 
relationship (p=0.01) but other Marsh classes did not show 
significant relations with this marker. Serum level of IL-6 
showed significant relationship with the severity of 
mucosal damage upon Marsh I, II and IIIC (p=0.000, 
p=0.02 and p=0.000 respectively) but not with Marsh 
class IIIA and IIIB. Similar to IL6, mean± SD serum level 
of TNF-a showed significant relationship with the severity 
of mucosal damage upon Marsh I, II and IIIC (p=0.03, 
p=0.05 and p=0.03 respectively) but not with Marsh class 
IIIA and IIIB. There is a positive relationship between 
mean± SD serum levels of IL6 and TNF-a with different 
 International Journal of Celiac Disease 56 
 
classes of Marsh classification from I to IIIC with the highest amounts in Marsh IIIC.  
Table 2. The relationship between Mean±SD of different serum markers and classes of intestinal involvements in celiac patients 
TNF-a IL-6 Hs-CRP Variable 
Marsh P-value Mean±SD P-value Mean±SD P-value Mean±SD 
0.03 5.07±1.3 0.0001 1.81±0.6 0.01 7.19±3.3 I 
0.05 5.87±2.9 0.02 2.39±0.9 0.9 8.19±3.1 II 
0.03 7.41±3.7 0.1 2.79±0.6 0.1 7.83±2.7 IIIA 
0.4 7.33±2.3 0.1 2.81±0.7 0.07 8.66±2.9 IIIB 
0.003 8.49±3.4 0.0001 3.16±0.6 0.3 8.32±3.2 IIIC 
Table 3. The cut of point scores related to different serum cytokines in comparison with Marsh classification among celiac patients 
Cut of point Mean± 2SD (95% CI) 
Variable Marsh 
IIIc N=58 
Marsh 
IIIb N=54 
Marsh 
IIIa N=46 
Marsh II 
N=72 
Marsh I 
N=44 
Marsh IIIc 
N=58 
Marsh IIIb 
N=54 
Marsh IIIa 
N=46 
Marsh II 
N=72 
Marsh I 
N=44 
4.4 4.4 4.2 3.9 3.1 3.3±1.1 (2.2-4.4) 
2.8±1.6 
(1.2-4.4) 
2.8±1.4 
(1.4-4.2) 
2.3±1.6 
(0.7-3.9) 
1.8±1.3 
(0.5-3.1) 
IL-6 
pg/ml 
15 - - - - 8.5±5.6 (2.7-15) 
8.3±17.8 (-
9.5-26.1) 
7.2±9.4 (-
2.2-16.6) 
6.3±6.7 (-
0.4-13) 
4.7±6.4 (-
1.7-11.1) 
TNF-a 
pg/ml 
14.8 14.6 13.3 13.3 - 8.3±6.5 (1.8-14.8) 
8.7±5.9 
(2.8-14.6) 
7.8±5.5 
(2.3-13.3) 
7.7±5.6 
(2.1-13.3) 
5.8±7.1 (-
1.3-12.9) 
CRP 
mg/l 
According to the results of this study the cut of points 
associated to the different serum levels of IL6 upon Marsh 
classification were different among celiac patients. The 
cut of point related to TNF-a was 15 only in Marsh IIIc 
and CRP serum level, similar to IL6, showed different 
figures upon Marsh classification (Table 3).  
 
Figure 1. The relationship between serum markers and severity of 
intestinal involvements in celiac patients upon Marsh classification 
4. Discussion 
Celiac is caused by damages of intestinal mucosa due to 
sensitivity to gluten amongst susceptible individuals and 
intestinal biopsy samples taken from these patients show 
villous atrophy accompanied with crypts hyperplasia and 
lymphocytes secretion [14]. The accepted pathologic 
concept in these patients is activation of T cell in lamina 
propia and production of Ab with autoimmune 
characteristics [15,16,17]. Different studies have reported 
that gluten experimentally stimulates the production of 
pre-inflammatory cytokines [13,18]. In the current study 
we evaluated the variations of serum levels of 
inflammatory markers including hs-CRP, IL-6 and TNF-a 
among celiac patients and also investigated any 
relationship between these variations and the severity of 
intestinal damages upon Modified Marsh classification. 
The majority of participants were female, however, there 
was no significant difference between mean serum level of 
these markers among male compared to female. Mean 
serum level of hs-CRP was high among patients with 
Marsh I significantly (p=0.01) but other Marsh classes did 
not show significant relations with this marker. There was 
a significant relationship between serum level of IL-6 and 
mucosal variations upon Marsh I, II and IIIC (p=0.000, 
p=0.02 and p=0.000 respectively) but not in Marsh classes 
of IIIA and IIIB. The same results were seen for the 
relations between serum level of TNF-a and mucosal 
variations upon Marsh classification. According to these 
results there is a positive relationship between serum 
levels of IL-6 and TNF-a with pathologic variations of 
intestinal mucosa upon Marsh classification. However, 
this phenomenon was not seen regularly for serum level of 
hs-CRP. There was no study so far to report the relation 
between serum levels of inflammatory markers and 
pathologic variations of intestinal mucosa among celiac 
patients. A study by Westerholm and others reported that 
the serum level of INF-y, IL-6 and IL-2 among celiac 
patients and susceptible individuals compared to control 
groups was higher [19]. Also another study showed that 
explanation of IL-2 gene among children with celiac 
disease was more than normal people [20]. Cataldo and 
coworkers indicated that patients with special IgA 
deficiency had a higher serum level of pre-inflammatory 
cytokines particularly the level of INF-y [21]. All 
associated studies have confirmed serum rising of 
inflammatory markers among celiac patients compared to 
control groups; however, the current study showed the 
significant and positive relation between mucosal 
variations and serum level of inflammatory markers. 
Cytokines inflammatory markers are increased in many 
diseases and therefore they are nonspecific markers in 
diagnosis of certain diseases, however, they are used 
widely in the clinic to help professionals in identification 
of some diseases when they are accompanied by other 
diagnostic criteria. In the current study we showed that 
increasing of these markers in the serum of celiac patients 
is common and their levels are increased when the 
pathological aspects of the disease are worsen on the basis 
of Marsh classification.  
According to the results of this study, on the basis of 
mean± 2SD we concluded that if the serum level of IL6 in 
a celiac patient was more than 3.1 pg/ml, with 95% 
confidence this patient has the celiac disease in 
accordance with Marsh I and if this figure was more than 
4.4 pg/ml, this patient has the celiac disease in accordance 
with Marsh IIIb or Marsh IIIc. The same interpretation 
could be applied for CRP serum levels; however, the cut 
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of point related to TNF-a (15 pg/ml) was only detected 
correctly in Mrash IIIc. Also this study introduced some 
serologic cut of points for IL6, TNF-a and CRP in related 
to each pathologic aspect (Marsh classes) of celiac disease 
which can be used as non invasive tools in classification 
of diseases' severity among celiac patients.  
This study has been performed among confirmed celiac 
patients and its main objective was to show any relation 
between mucosal variations and serum levels of 
inflammatory markers upon pathologic findings. 
Therefore other clinical features of this disease were not 
compared to the variations of serum levels of studied 
cytokines in this study and need to be investigated by 
further studies.  
5. Conclusion  
According to the results of this study, the severity of 
mucosal damages in celiac patients was associated with 
the changes of serum level of inflammatory markers and 
this process can help to find a non-invasive method for 
severity prediction of celiac disease and selection of 
proper medical interventions. Different cut of points 
associated to the different serum levels of IL6, TNF-a and 
CRP upon Marsh classification were identified among 
celiac patients.  
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